A Massachusetts federal judge rejected a whistleblower’s lawsuit Tuesday against Ireland-based Covidien’s subsidiary ev3 inc., accusing the company of promoting a blood-blocking surgical device for off-label purposes and other misconduct. Former ev3 salesman Jeffrey D’Agostino filed the lawsuit under the qui tam, or whistleblower, provisions of the False Claims Act against ev3, executive salesman Brett Wall, and Vice President of Sales and Global Marketing John Hardin. Mr. D’Agostino sued on behalf of the U.S. government and 26 states. U.S. District Judge Richard Stearns rejected Mr. D’Agostino’s lawsuit citing weak allegations and insufficient evidence. The lawsuit accuses ev3 of submitting false ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.